Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein
Mustafa Yalcınkaya, Wenli Liu, Mohammad Naimul Islam, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway
Huanzhou Xu, Ibukun A. Akinyemi, Siddhi Chitre, et al.
Virology (2022) Vol. 568, pp. 13-22
Open Access | Times Cited: 136
SARS-CoV-2 biology and host interactions
Silvio Steiner, Annika Kratzel, G. Tuba Barut, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 4, pp. 206-225
Closed Access | Times Cited: 83
SARS-CoV-2 E protein: Pathogenesis and potential therapeutic development
Shilin Zhou, Panpan Lv, Mingxue Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114242-114242
Open Access | Times Cited: 45
Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19
Paôline Laurent, Chao Yang, André F. Rendeiro, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 63
Lowered Quality of Life in Long COVID Is Predicted by Affective Symptoms, Chronic Fatigue Syndrome, Inflammation and Neuroimmunotoxic Pathways
Michaël Maes, Haneen Tahseen Al-Rubaye, Abbas F. Almulla, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 16, pp. 10362-10362
Open Access | Times Cited: 42
Chronic Fatigue, Depression and Anxiety Symptoms in Long COVID Are Strongly Predicted by Neuroimmune and Neuro-Oxidative Pathways Which Are Caused by the Inflammation during Acute Infection
Hussein Kadhem Al‐Hakeim, Haneen Tahseen Al-Rubaye, Abbas F. Almulla, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 511-511
Open Access | Times Cited: 40
Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms
Brent Brown, Vanshika Ojha, Ingo Fricke, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 37
NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis
Nicola Potere, Evan Garrad, Yogendra Kanthi, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 11, pp. 2046-2060
Open Access | Times Cited: 31
SARS-CoV-2 envelope protein impairs airway epithelial barrier function and exacerbates airway inflammation via increased intracellular Cl− concentration
Jian-Bang Xu, Wei‐jie Guan, Yilin Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 12
Inflammasome Activation by RNA Respiratory Viruses: Mechanisms, Viral Manipulation, and Therapeutic Insights
Tamara Silva Rodrigues, Dario S. Zamboni
Immunological Reviews (2025) Vol. 330, Iss. 1
Closed Access | Times Cited: 1
Potential benefits of ginseng against COVID-19 by targeting inflammasomes
Young‐Su Yi
Journal of Ginseng Research (2022) Vol. 46, Iss. 6, pp. 722-730
Open Access | Times Cited: 36
NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes.
Debashis Dutta, Jianuo Liu, Huangui Xiong
PubMed (2022) Vol. 14, Iss. 3, pp. 138-160
Closed Access | Times Cited: 34
Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: from prognostic marker to therapeutic agent
Jozefien Declercq, Elisabeth De Leeuw, Bart N. Lambrecht
Cytokine (2022) Vol. 157, pp. 155934-155934
Open Access | Times Cited: 30
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
Yash Gupta, Oleksandr V. Savytskyi, Matt Coban, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101151-101151
Open Access | Times Cited: 30
NLRP3 Inflammasome’s Activation in Acute and Chronic Brain Diseases—An Update on Pathogenetic Mechanisms and Therapeutic Perspectives with Respect to Other Inflammasomes
Anna Chiarini, Li Gui, C Viviani, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 999-999
Open Access | Times Cited: 23
SARS-CoV-2-Mediated Lung Edema and Replication Are Diminished by Cystic Fibrosis Transmembrane Conductance Regulator Modulators
José M. Honrubia, Francisco J. Gutierrez-Alvarez, Alejandro Sanz‐Bravo, et al.
mBio (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology
Man Wang, Fei Yu, Wenguang Chang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Differences and similarities between innate immune evasion strategies of human coronaviruses
Helene Hoenigsperger, Rinu Sivarajan, Konstantin M. J. Sparrer
Current Opinion in Microbiology (2024) Vol. 79, pp. 102466-102466
Open Access | Times Cited: 8
SARS-CoV-2 ORF3a Protein as a Therapeutic Target against COVID-19 and Long-Term Post-Infection Effects
Jiantao Zhang, Kellie Hom, Chen‐Yu Zhang, et al.
Pathogens (2024) Vol. 13, Iss. 1, pp. 75-75
Open Access | Times Cited: 7
Activation and Regulation of NLRP3 by Sterile and Infectious Insults
Srijon K. Banerjee, Ayan Chatterjee, Shamba Gupta, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity
Julio García-Villalba, Laura Hurtado‐Navarro, Alejandro Peñín‐Franch, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
The role of the NLRP3 inflammasome in chronic inflammation in asthma and chronic obstructive pulmonary disease
Yaxin Wu, Xin Di, Min Zhao, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 12
Open Access | Times Cited: 23
SARS-CoV-2 envelope protein regulates innate immune tolerance
Eric S. Geanes, Rebecca McLennan, Stephen Pierce, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109975-109975
Open Access | Times Cited: 6
Tranilast as an Adjunctive Therapy in Hospitalized Patients with Severe COVID- 19: A Randomized Controlled Trial
Ali Saeedi-Boroujeni‬, Roohangiz Nashibi, Ata Ghadiri, et al.
Archives of Medical Research (2022) Vol. 53, Iss. 4, pp. 368-377
Open Access | Times Cited: 20
Investigating the Nexus of NLRP3 Inflammasomes and COVID-19 Pathogenesis: Unraveling Molecular Triggers and Therapeutic Strategies
Qun He, Da Hu, Fuqiang Zheng, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 213-213
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top